Zepzelca (lurbinectedin)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Zepzelca (lurbinectedin), covering 2025-02-28 to 2025-12-29. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer [Phase 3]